Stock Groups

Align Earnings, Revenue Beat in Q3 -Breaking

by Mike Robinson

[ad_1]

© Reuters. Align earnings, revenue beat in Q3

Align (NASDAQ 🙂 announced Wednesday the results of its third quarter. The revenue beat forecasts by analysts.

Align posted earnings per share in the range of $2.87 to $1.02B on revenues of $976.89M. Investing.com polled analyst to predict EPS of 2.59 on revenues of $976.89M.

Align shares have fallen 5% since the start of the year. However, they are still 18.00% below the 52-week high of $737.45 on September 23. These shares are outperforming the Nasdaq, which has risen 18.21% since the beginning of the year.

Following the publication, Align shares rose 8.32% after hours trade.

Align reports on other important earnings from the Healthcare sector this month

Align’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.

Thermo Fisher Scientific’s third quarter earnings per share (EPS) was $5.76 on $9.33B in revenue, beating expectations. This compares to the forecasted $4.68 on $8.33B revenue.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar

Disclaimer Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, futures, indexes and Forex. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]